European Commission call for data on Cannabidiol (CBD)
Ingredients: CANNABIDIOL (CBD)

Date of publication: 01/06/2023

the European Commission launched a call for data on the safety of Cannabidiol (CBD) in pure form, as well as an extract that may contain contaminants of other cannabinoids, including THC at trace levels.

Background

Cannabidiol (CBD) (CAS No. 13956-29-1, EC No. 689-176-3) with the chemical name ‘2-[(6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol’ is included in the European database for information on cosmetic substances and ingredients (CosIng) with the reported functions of ‘skin conditioning’, ‘skin protecting’, ‘antioxidant’, ‘anti-sebum’, etc.

Currently, CBD as such is not regulated under EU Cosmetics Regulation (EC) No 1223/2009. However, entry 306 of Annex II to the EU Cosmetics Regulation prohibits ‘Narcotics, natural and synthetic: All substances listed in Tables I and II of the Single Convention on narcotic drugs signed in New York on 30 March 1961’ for use in cosmetic products.

On 19 November 2020, the Court of Justice of the EU (CJEU) delivered a judgment in Case C-
663/185 concerning the legal status of cannabidiol. In the judgement, the CJEU concluded that
CBD at stake in the main proceedings, should not be considered as a drug under the UN Single
Convention on Narcotic Drugs of 1961.

What’s new?

On 1 June 2023, the European Commission launched a call for data on the safety of Cannabidiol (CBD) (CAS No. 13956-29-1, EC No. 689-176-3) in pure form, as well as an extract that may contain contaminants of other cannabinoids, including trans-Δ⁹-tetrahydrocannabinol (THC or delta-9-THC) (CAS No. 1972-08-3, EC No. 625-153-6), at trace levels.

Considering the very limited available information regarding the safety of CBD in cosmetic
products, the main objective of this call is to gather relevant scientific information to enable the Scientific Committee on Consumer Safety (SCCS) to perform a safety assessment.

Any interested parties, including academic and other research institutes, EU countries’ authorities, manufacturers of cosmetic products, producers of Cannabidiol (CBD) and consumers associations, are invited by the European Commission to submit any relevant scientific information.

Period of consultation: from 1 June 2023 to 30 September 2024 (15 months)

References:

European Commission – Call for data on ingredients used in cosmetic products

other REGULATORY UPDATES

Regulation (EU) 2022/692 – OMNIBUS ACT VI – New and Updated Classification of Cosmetic Ingredients

Ingredients: BENZOPHENONE, TEOPHYLLINE, MELAMINE, AZADIRACHTA EXTRACTS, TRIMETHYLOLPROPANE TRIACRYLATE, PENTETIC ACID, PENTASODIUM PENTETATE

Date of publication: 03/05/2022

Date of application: 01/12/2023

The Commission Delegated Regulation (EU) 2022/692 includes new or updated classification for 12 chemicals that may be used as cosmetic ingredients. Seven out of these 12 are now classified as carcinogenic, mutagenic or toxic to reproduction (CMR) and are banned from cosmetic products marketed in the EU.

Read More »

SCCS Revision of the Scientific Opinion on Vitamin A

Ingredients: RETINOL, RETINYL PALMITATE, RETINYL ACETATE, RETINYL LINOLEATE, RETINAL

Date of publication: 25/10/2022

The Scientific Committee on Consumer Safety has issued a final version of the Scientific Opinion on Vitamin A, concluding that exposure to Vitamin A derived from cosmetics can be a concern for higher exposure consumers, and since cosmetics alone do not exceed the upper limit the SCCS cannot suggest maximum concentration limits that take into account contributions from other sources.

Read More »
Any REGULATORY QUESTION?

Regulation (EU) 2022/692 – OMNIBUS ACT VI – New and Updated Classification of Cosmetic Ingredients

Ingredients: BENZOPHENONE, TEOPHYLLINE, MELAMINE, AZADIRACHTA EXTRACTS, TRIMETHYLOLPROPANE TRIACRYLATE, PENTETIC ACID, PENTASODIUM PENTETATE

Date of publication: 03/05/2022

Date of application: 01/12/2023

The Commission Delegated Regulation (EU) 2022/692 includes new or updated classification for 12 chemicals that may be used as cosmetic ingredients. Seven out of these 12 are now classified as carcinogenic, mutagenic or toxic to reproduction (CMR) and are banned from cosmetic products marketed in the EU.

Read More »

SCCS Preliminary Opinion on Sodium Bromothymol Blue (C186) as hair dyeing

Ingredients: SODIUM BROMOTHYMOL BLUE (C186)

Date of publication: 28/10/2022

Following the request from the EU Commission for a scientific opinion on the hair dye Sodium Bromothymol Blue (C186), on October 2022 the Scientific Committee on Consumer Safety (SCCS) issued a preliminary opinion. In light of the data provided, when used in non-oxidative hair colouring products up to a maximum on-head concentration of 0.5%, the SCCS is of the opinion that the complete safety of Sodium Bromothymol Blue could not be assessed.

Read More »

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »